Reply

Binu V John^{1

2}, Bassam Dahman³

Affiliations

¹ Division of Gastroenterology and Hepatology , Miami VA Health System , Miami , Florida , USA.
² Division of Digestive Health and Liver Diseases , University of Miami Miller School of Medicine , Miami , Florida , USA.
³ Department of Health Behavior and Policy , Virginia Commonwealth University , Richmond , Virginia , USA.

Binu V John et al. Hepatology. 2023.

. 2023 Jan 1;77(1):E14-E16.

doi: 10.1002/hep.32748. Epub 2022 Sep 11.

Binu V John^{1

2}, Bassam Dahman³

¹ Division of Gastroenterology and Hepatology , Miami VA Health System , Miami , Florida , USA.
² Division of Digestive Health and Liver Diseases , University of Miami Miller School of Medicine , Miami , Florida , USA.
³ Department of Health Behavior and Policy , Virginia Commonwealth University , Richmond , Virginia , USA.

No abstract available

Conflict of interest statement

Binu John received grants from Exact Sciences, Gilead, Glycotest, and Exelixis.

1. John BV, Barritt AS IV, Moon A, Taddei TH, Kaplan DE, Dahman B, et al. Effectiveness of COVID‐19 viral vector Ad.26.COV2.S vaccine and comparison with mRNA vaccines in cirrhosis. Clin Gastroenterol Hepatol. 2022. June 16. 10.1016/j.cgh.2022.05.038. [Epub ahead of print] - DOI - PMC - PubMed
1. John BV, Deng Y, Scheinberg A, Mahmud N, Taddei TH, Kaplan D, et al. Association of BNT162b2 mRNA and mRNA‐1273 vaccines with COVID‐19 infection and hospitalization among patients with cirrhosis. JAMA Intern Med. 2021;181:1306–14. - PMC - PubMed
1. John BV, Doshi A, Ferreira RD, Taddei TH, Kaplan DE, Spector SA, et al. Comparison of infection‐induced and vaccine‐induced immunity against COVID‐19 in patients with cirrhosis. Hepatology. 2022. June 16. 10.1002/hep.32619. [Epub ahead of print] - DOI - PubMed
1. Marjot T, Moon AM, Cook JA, Abd‐Elsalam S, Aloman C, Armstrong MJ, et al. Outcomes following SARS‐CoV‐2 infection in patients with chronic liver disease: an International Registry Study. J Hepatol. 2021;74:567–77. - PMC - PubMed